Prakt. lékáren. 2020; 16(3): 123-130

Acute upper respiratory tract infections and its management

Miloš Jeseňák1, Daniela Mináriková2
1 Klinika dětí a dorostu, Klinika pneumologie a ftizeologie, Oddělení klinické imunologie a alergologie, Jesseniova lékařská fakulta v Martině, Univerzita Komenského v Bratislavě, Univerzitní nemocnice Martin
2 Katedra organizace a řízení farmacie, Farmaceutická fakulta, Univerzita Komenského v Bratislavě

Acute upper respiratory tract (URT) infections are the most common diseases in which assisted self-medication is used with active participation of pharmacists. The article describes clinical signs and differential diagnosis of acute URT infections. The basis of rational management is early immunomodulatory treatment using support of body´s own natural antiviral immune mechanisms, symptomatic treatment, hygiene of the nasal mucosa together with regime and general hygiene measures. Zinc has complex immunomodulatory and antiviral effects.

Keywords: respiratory infections, upper respiratory tract, common cold, immunomodulation, zinc, self-medication.

Published: October 8, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jeseňák M, Mináriková D. Acute upper respiratory tract infections and its management. Praktické lékárenství. 2020;16(3):123-130.
Zobrazit celý článek

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Worrall G. Common cold. Can Fam Physician 2011; 57(11): 1289-1290. Go to original source... Go to PubMed...
    2. Collins JC, Moles RJ. Management of respiratory disorders and the pharmacist's role: cough, colds, and sore throats and allergies (including eyes). Encyclopedia of Pharm Pract Clin Pharm 2019; 282-291. Go to original source...
    3. Bennadi D. Self-medication: A current challenge. J Basic Clin Pharm 2013; 5(1): 19-23. Go to original source... Go to PubMed...
    4. Kotolová H. Symptomatická léčba chřipky a nachlazení. Doporučený postup, Česká lékárnická komora, 13. 12. 2018. On-line. [cit. 2020-08-17]. Dostupné na https://www.lekarnici.cz/Pro-verejnost/PORADENSTVI-KONZULTACE/PORADENSTVI---KONZULTACE/Doporuceny-postup-Chripka-a-nachlazeni.aspx.
    5. Jeseňák M, et al. Recidivujúce infekcie dýchacích ciest a imunomodulácia u detí. Praha: Mladá Fronta, a.s., 2012: 632 ss.
    6. Jesenak M, Urbancikova I, Banovcin P. Respiratory tract infections and the role of biologically-active polysaccharides inn their management and prevention. Nutrients 2017; 9: 779. Go to original source... Go to PubMed...
    7. Allan GM, Arroll B. Prevention and treatment of common cold making sence of the evidence. CMAJ 2014; 186: 190-199. Go to original source... Go to PubMed...
    8. Fashner J, Ericson K, Werner S. Treatment of the common cold in children and adults. Am Fam Phys 2012; 86: 153-159.
    9. West JV. Acute upper airway infections. Br Med Bull 2002; 61: 215-230. Go to original source... Go to PubMed...
    10. Fokkens WJ, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology 2020; 58: 82-111. Go to original source... Go to PubMed...
    11. Jesenak M, et al. Immune parameters and COVID-19 infection - associations with clinical severity and diseases prognosis. Front Cell Infect Microbiol 2020; 10: 264. Go to original source... Go to PubMed...
    12. Jeseňák M. Zinok a imunitný systém. Súč Klin Pr 2017; 2: 24-28.
    13. DeGeorge KC, Ring DJ, Dalrymple SN. Treatment of the common cold. Am Fam Physician 2019; 100: 281-289. Go to PubMed...
    14. Haran JP, et al. C-reactive protein as predictor of bacterial infection among patients with influenza-like illness. Am J Emerg Med 2013; 31: 137-144. Go to original source... Go to PubMed...
    15. Korpi M, Kroger L. C-reactive protein in viral and bacterial respiratory infection in children. Scand J Infect Dis 1992; 25: 207-213. Go to original source... Go to PubMed...
    16. Gažová A, Valášková S, Kyselovič, J. Terapia vírusových infekcií horných dýchacích ciest multisymptomatickými liečivami. Prakt lekárn 2016; 6: 13-15.
    17. Kršiak M, et al. Optimální dávkování paracetamolu při léčbě bolesti a horečky. Pediatr pro Praxi 2010; 11: 21-25.
    18. Geročová T. Ibuprofén očami súčasného lekárnika. Prakt lekárn 2012; 2: 52-59.
    19. Jeseňák M, Bánovčin P. Horúčka v detskom veku. Štandardný postup MZ SR, 1. máj 2020.
    20. Kovács L. Horúčka a horúčka neznámeho pôvodu. Pediatr prax 2007; 2: 94-99.
    21. Hemila H, et al. Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial. BMJ Open 2020; 10: e031662. Go to original source... Go to PubMed...
    22. Hemila H. Zinc lozenges may shorten the duration of colds: a systematic review. Open Respir Med J 2011; 5: 51-58. Go to original source... Go to PubMed...
    23. Read SA, et al. The role of zinc in antiviral immunity. Adv Nutr 2019; 10: 696-710. Go to original source... Go to PubMed...
    24. Skalny AV, et al. Zinc and respiratory tract infections: perspectives for COVID-19. Int J Mol Med 2020; 46: 17-26. Go to original source... Go to PubMed...
    25. Singh M, Das RR. Zinc for the common cold. Cochrane Databas Syst Rev 2013; 6: CD001364. Go to original source... Go to PubMed...
    26. Mousa HAL. Prevention and treatment of influenza, influenza-like illness, and common cold by herbal, complementary, and natural therapies. J Evid Based Compl Altern Med 2017; 22: 166-174. Go to original source... Go to PubMed...
    27. Hemila H. Vitamin C and infections. Nutrients 2017; 9: 339. Go to original source... Go to PubMed...
    28. Linde K, et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2014; 24554461. Go to original source...
    29. Urbancikova I, et al. Efficacy of pleuran (β-glucan from Pleurotus ostreatus) in the management of herpes simplex virus type 1 infection. Evid Based Complementary Altern Med 2020; 2020: 8562309. Go to original source... Go to PubMed...
    30. Bystroň J. Využití bakteriálních lyzátů v klinické praxi. Pediatr praxi 2011; 12: 398-404.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.